- Home
- PRTA vs BYRN Comparison
PRTA vs BYRN Comparison
Compare PRTA & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- BYRN
- Stock Information
- Founded
- PRTA 2012
- BYRN 2005
- Country
- PRTA Ireland
- BYRN United States
- Employees
- PRTA N/A
- BYRN N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- BYRN Industrial Machinery/Components
- Sector
- PRTA Health Care
- BYRN Miscellaneous
- Exchange
- PRTA Nasdaq
- BYRN Nasdaq
- Market Cap
- PRTA 472.1M
- BYRN 485.6M
- IPO Year
- PRTA N/A
- BYRN N/A
- Fundamental
- Price
- PRTA $8.16
- BYRN $20.03
- Analyst Decision
- PRTA Buy
- BYRN Strong Buy
- Analyst Count
- PRTA 10
- BYRN 2
- Target Price
- PRTA $12.29
- BYRN $41.50
- AVG Volume (30 Days)
- PRTA 935.9K
- BYRN 480.4K
- Earning Date
- PRTA 11-11-2025
- BYRN 10-08-2025
- Dividend Yield
- PRTA N/A
- BYRN N/A
- EPS Growth
- PRTA N/A
- BYRN N/A
- EPS
- PRTA N/A
- BYRN 0.62
- Revenue
- PRTA $10,341,000.00
- BYRN $103,528,000.00
- Revenue This Year
- PRTA N/A
- BYRN $38.01
- Revenue Next Year
- PRTA $389.77
- BYRN $21.31
- P/E Ratio
- PRTA N/A
- BYRN $32.20
- Revenue Growth
- PRTA N/A
- BYRN 73.56
- 52 Week Low
- PRTA $4.32
- BYRN $13.10
- 52 Week High
- PRTA $22.71
- BYRN $34.78
- Technical
- Relative Strength Index (RSI)
- PRTA 51.80
- BYRN 46.34
- Support Level
- PRTA $8.19
- BYRN $19.37
- Resistance Level
- PRTA $8.50
- BYRN $21.87
- Average True Range (ATR)
- PRTA 0.33
- BYRN 1.37
- MACD
- PRTA -0.09
- BYRN 0.19
- Stochastic Oscillator
- PRTA 16.18
- BYRN 36.45
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.